-
-
-
-
-
-
-
Rigel reports Q4 revenue of $69.8 million, projects 2026 growth
-
-
-
-
-
-
-
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update
-
-
-
-
-
-
-
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
-
-
-
-
-
-
Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update
-
-
-
-
-
-
-
Rigel Pharma (RIGL) Acquires U.S. Rights to GAVRETO from Blueprint Medicines (BPMC)
-
-
-
-
-
-
-
Rigel Pharma (RIGL) Tops Q2 EPS by 12c
-
-
-
-
-
-
-
Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
1,199,634 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

